TIDMTTM TIDMHLO TIDMTTM
RNS Number : 7321D
Angel Acquisitions Limited
01 May 2013
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN
PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA OR
JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE
UNLAWFUL
1 May 2013
RECOMMENDED OFFER
By
ANGEL ACQUISITIONS LTD
For
HEALTHCARE LOCUMS PLC
UPDATE OF ACCEPTANCES AND INTENTION TO DELIST
Introduction
On 11 April 2013, the Board of Directors of Angel Acquisitions
Limited ("Angel Acquisitions") and the Board of Directors of
Healthcare Locums plc ("HCL") announced the terms of a recommended
offer to be made by Angel Acquisitions to acquire the entire issued
ordinary share capital of HCL (the "Offer"). The full terms and
conditions of the Offer and the procedures for acceptance were set
out in the offer document issued by Angel Acquisitions on 17 April
2013 (the "Offer Document"). The Offer was declared unconditional
in all respects on 22 April 2013.
Level of acceptances
As at 7 am on 22 April 2013 Angel Acquisitions owned 589,969,453
HCL Shares, representing approximately 69.59% of the entire issued
share capital of HCL, acquired from ACE Holdco and Tosca
Opportunity (the "Acquired Shares"). The Offer did not relate to
the Acquired Shares, which were acquired pursuant to the terms of a
Joint Venture Agreement between Angel Acquisitions, Tosca
Opportunity, ACE Holdco and Ares Europe, and not pursuant to the
Offer.
As at 5 pm on 30 April 2013, Angel Acquisitions has received
valid acceptances from Healthcare Locums plc Shareholders in
respect of 30,489,924 HCL Shares representing approximately 3.60
per cent. of the issued HCL Shares.
As at 5 pm on 30 April 2013, Angel Acquisitions has acquired
35,184,367 HCL Shares representing approximately 4.15 per cent. of
the entire issued HCL Shares.
The total number of HCL shares now held by Angel Acquisitions
and persons acting in concert with it, together with those for
which valid acceptances of the Offer have been received is
therefore 655,643,744 HCL Shares representing approximately 77.33
per cent. of the issued HCL Shares.
Intention to delist
As set out in paragraph 12 of Part II of the Offer Document, now
that the Offer has become unconditional in all respects and Angel
Acquisitions has acquired or received valid acceptances in respect
of more than 75 per cent. of the voting rights of HCL, Angel
Acquisitions has requested that HCL applies to AIM for the
cancellation of admission to trading on AIM of HCL Shares.
HCL has confirmed to Angel Acquisitions that the expected date
of cancellation is 3 June 2013.
Such cancellation of admission to trading is likely to
significantly reduce the liquidity and marketability of any HCL
Shares not assented to the Offer.
In due course, Angel Acquisitions will seek to re-register HCL
as a private company.
Capitalised terms used in this announcement have the same
meanings given to them in the Offer Document unless stated
otherwise. All references to time in this announcement are to
London time.
Enquiries:
Canaccord Genuity (financial adviser to Angel Acquisitions and
the Consortium)
Andrew Speirs Tel: +44 (0) 20 7665 4500
David Tyrrell
Canaccord Genuity, which is authorised and regulated in the UK
by the Financial Conduct Authority, is acting exclusively for Angel
Acquisitions and the Consortium and no one else in connection with
the Offer and will not be responsible to anyone other than Angel
Acquisitions and the Consortium for providing the protections
afforded to clients of Canaccord Genuity or for providing advice in
relation to the Offer or any other matters referred to in this
announcement.
This announcement is not intended to and does not constitute an
offer to sell, or form part of, or constitute the solicitation of
an offer to purchase or subscribe for or an invitation to purchase,
any securities.
The directors of Angel Acquisitions accept responsibility for
the information contained in this announcement. To the best of the
knowledge and belief of the directors of Angel Acquisitions (who
have taken all reasonable care to ensure that such is the case),
the information contained in this document is in accordance with
the facts and does not omit anything likely to affect the import of
such information.
Dealing Disclosure Requirements
Under Rule 8.3(a) of the City Code, any person who is interested
in 1 per cent. or more of any class of relevant securities of an
offeree company or of any paper offeror (being any offeror other
than an offeror in respect of which it has been announced that its
offer is, or is likely to be, solely in cash) must make an Opening
Position Disclosure following the commencement of the Offer Period,
and, if later, following the announcement in which any paper
offeror is first identified. An Opening Position Disclosure must
contain details of the person's interests and short positions in,
and rights to subscribe for, any relevant securities of each of (i)
the offeree company and (ii) any paper offeror(s). An Opening
Position Disclosure by a person to whom Rule 8.3(a) applies must be
made by no later than 3.30 p.m. (London time) on the 10th business
day following the commencement of the Offer Period and, if
appropriate, by no later than 3.30 p.m. (London time) on the 10th
business day following the announcement in which any paper offeror
is first identified. Relevant persons who deal in the relevant
securities of the offeree company or of a paper offeror prior to
the deadline for making an Opening Position Disclosure must instead
make a Dealing Disclosure.
Under Rule 8.3(b) of the City Code, any person who is, or
becomes, interested in 1 per cent. or more of any class of relevant
securities of the offeree company or of any paper offeror must make
a Dealing Disclosure if the person deals in any relevant securities
of the offeree company or of any paper offeror. A Dealing
Disclosure must contain details of the dealing concerned and of the
person's interests and short positions in, and rights to subscribe
for, any relevant securities of each of (i) the offeree company and
(ii) any paper offeror(s), save to the extent that these details
have previously been disclosed under Rule 8. A Dealing Disclosure
by a person to whom Rule 8.3(b) applies must be made by no later
than 3.30 p.m. (London time) on the business day following the date
of the relevant dealing.
If two or more persons act together pursuant to an agreement or
understanding, whether formal or informal, to acquire or control an
interest in relevant securities of an offeree company or a paper
offeror, they will be deemed to be a single person for the purpose
of Rule 8.3.
Opening Position Disclosures must also be made by the offeree
company and by any offeror and Dealing Disclosures must also be
made by the offeree company, by any offeror and by any persons
acting in concert with any of them (see Rules 8.1, 8.2 and
8.4).
Details of the offeree and offeror companies in respect of whose
relevant securities Opening Position Disclosures and Dealing
Disclosures must be made can be found in the Disclosure Table on
the Takeover Panel's website at www.thetakeoverpanel.org.uk,
including details of the number of relevant securities in issue,
when the Offer Period commenced and when any offeror was first
identified. You should contact the Panel's Market Surveillance Unit
on +44(0)20 7638 0129 if you are in any doubt as to whether you are
required to make an Opening Position Disclosure or a Dealing
Disclosure.
Overseas Jurisdictions
The release, publication or distribution of this announcement in
jurisdictions other than the United Kingdom may be restricted by
the laws and/or regulations of those jurisdictions. In addition,
the availability of the Offer to persons who are resident in
jurisdictions other than the United Kingdom may be restricted by
the laws and/or regulations of the relevant jurisdictions in which
they are located. Persons into whose possession this announcement
comes should inform themselves about, and observe, any applicable
requirements in their jurisdiction. Any failure to comply with the
applicable requirements may constitute a violation of the
securities laws and/or regulations of any such jurisdiction.
In particular, copies of this announcement and any other formal
documentation relating to the Offer are not being, and must not be,
directly or indirectly, mailed or otherwise forwarded, distributed
or sent in or into or from any Restricted Jurisdiction and persons
receiving such documents (including custodians, nominees and
trustees) must not mail or otherwise forward, distribute or send
any of them in or into or from any Restricted Jurisdiction. Unless
otherwise permitted by applicable law and regulation, the Offer may
not be made directly or indirectly, in or into, or by the use of
mails or any means or instrumentality (including, but not limited
to, facsimile, e-mail or other electronic transmission, telex or
telephone) of interstate or foreign commerce of, or of any facility
of a national, state or other securities exchange of any Restricted
Jurisdiction and the Offer may not be capable of acceptance by any
such use, means, instrumentality or facilities.
This announcement has been prepared for the purposes of
complying with English law and the City Code and the information
disclosed may not be the same as that which would have been
disclosed if this announcement had been prepared in accordance with
the laws and regulations of any jurisdiction outside of
England.
This information is provided by RNS
The company news service from the London Stock Exchange
END
OUPUGURUAUPWUBG
Healthcare Locums (LSE:HLO)
過去 株価チャート
から 10 2024 まで 11 2024
Healthcare Locums (LSE:HLO)
過去 株価チャート
から 11 2023 まで 11 2024
